Vaccsys raises $9 million for vaccine research
Vaccsys, a company that does vaccine research, has raised $9 million of a planned $18 million round from Alta Partners, Versant Venture Capital and The Column Group.
Vaccsys’s web site is here, although it’s still under construction.
Update: As part of the new funding, Vaccsys is relaunching under a new name, Immune Design, according to VentureWire.
Defibrillator maker Cameron Health takes in $14M
Cameron Health, a San Clemente, Calif., medical-device maker, has raised $14.1 million of a planned $50 million fifth funding round, I’ve learned. The company is working on a new type of implantable defibrillator that’s designed to be easier to implant and program than existing models.
Implantable defibrillators administer shocks to the hearts of people who are at risk of cardiac arrest — a critical condition in which the heart simply stops beating. When the device senses… Continue Reading